1
|
Moraes FCAD, Santos RRDE, Campos JCD, Mota ACC, Pessoa FR, Sarges DC, Moraes DA, Souza DDSMD. Covid-19 and Heart Involvement: A Systematic Review of Literature. INTERNATIONAL JOURNAL OF CARDIOVASCULAR SCIENCES 2023. [DOI: 10.36660/ijcs.20220035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
|
2
|
Noghabaei G, Arab M, Payami S, Ghavami B. Acute Pericarditis as the Primary Presentation of COVID-19 Infection followed by Guillain-Barre Syndrome in a Healthy Young Man: A Case Report. Open Respir Med J 2022. [DOI: 10.2174/18743064-v16-e221020-2022-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Background:
Symptomatic COVID-19 infection most often presents as acute respiratory distress syndrome. Acute pericarditis and Guillain–Barré syndrome are rare extrapulmonary manifestations of this infection.
Case Presentation:
A 27-year-old man presented with chest pain, with negative troponin and typical electrocardiographic findings, resulting in a diagnosis of acute pericarditis. He had no respiratory symptoms, nor the chest computerized tomography (CT) scan findings of COVID-19, and his Polymerase chain reaction (PCR) was negative. One week later, he developed clinical symptoms of Guillain-Barre syndrome, along with respiratory manifestations of COVID-19. His repeat chest CT scan and PCR test confirmed COVID-19 infection. After 17 days of hospital stay, he improved clinically and was discharged.
Conclusion:
This is the first case of acute pericarditis as the primary presentation of COVID-19 in the absence of respiratory symptoms and a clear chest CT scan, followed by the development of Guillain–Barré syndrome and respiratory tract manifestations of COVID-19. Clinicians should be aware of the extrapulmonary presentation of COVID-19 infection.
Collapse
|
3
|
Benramdane H, Nasri S, Ouahabi N, Belharti A, Chehita K, Yassine M, Housni B, Skiker I. Multiple ischemic stroke with pulmonary embolism revealing severe COVID-19 infection in a young healthy patient. Radiol Case Rep 2022; 17:4879-4884. [PMID: 36247700 PMCID: PMC9557746 DOI: 10.1016/j.radcr.2022.08.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 08/01/2022] [Accepted: 08/08/2022] [Indexed: 11/26/2022] Open
Abstract
Coronavirus 2019 (COVID-19) disease has caused significant morbidity and mortality worldwide since its emergence in December 2019. Despite its respiratory tropism; there is a nontrivial relationship between this virus and the neurovascular system exposing patients to higher morbidity and mortality. We report the case of a young patient admitted for hemiplegia with acute respiratory failure, in whom imaging found multiple ischemic strokes with pulmonary embolism and severe involvement suggestive of COVID-19 pneumopathy. Stroke in the context of COVID-19 infection has distinct characteristics in terms of disease mechanism, patient demographics, but also clinical, biological, and neuroradiological specificities. The pathogenesis and optimal management of COVID-19-associated ischemic stroke remain unclear, but the coagulopathy and endotheliopathy triggered by the cytokine storm represent possible target mechanisms.
Collapse
Affiliation(s)
- Hicham Benramdane
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Radiology, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco,Corresponding author.
| | - Siham Nasri
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Radiology, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Nada Ouahabi
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Aahd Belharti
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Radiology, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Kaouthar Chehita
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Neurology, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Mebrouk Yassine
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Neurology, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Brahim Housni
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Imane Skiker
- Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco,Department of Radiology, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| |
Collapse
|
4
|
Theetha Kariyanna P, Sabih A, Sutarjono B, Shah K, Vargas Peláez A, Lewis J, Yu R, Grewal ES, Jayarangaiah A, Das S, Jayarangaiah A. A Systematic Review of COVID-19 and Pericarditis. Cureus 2022; 14:e27948. [PMID: 36120210 PMCID: PMC9464705 DOI: 10.7759/cureus.27948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/11/2022] [Indexed: 11/16/2022] Open
Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China in December 2019. Since then, the disease has spread globally, leading to the ongoing pandemic. It can cause severe respiratory illness; however, many cases of pericarditis have also been reported. This systematic review aims to recognize the clinical features of pericarditis and myopericarditis in COVID-19 patients. Google Scholar, Medline/PubMed, CINAHL, Cochrane Central, and Web of Science databases were searched for studies reporting “Coronavirus” or “COVID” and “Peri-myocarditis,” “heart,” or “retrospective.” Case reports and retrospective studies published from May 2020 to February 2021 were reviewed. In total, 33 studies on pericarditis, myopericarditis, and pericardial infusion were included in this review. COVID-19 pericarditis affected adult patients at any age. The incidence is more common in males, with a male-to-female ratio of 2:1. Chest pain (60%), fever (51%), and shortness of breath (51%) were the most reported symptoms, followed by cough (39%), fatigue (15%), myalgia (12%), and diarrhea (12%). Laboratory tests revealed leukocytosis with neutrophil predominance, elevated D-dimer, erythrocyte rate, and C-reactive protein. Cardiac markers including troponin-1, troponin-T, and brain natriuretic peptide were elevated in most cases. Radiographic imaging of the chest were mostly normal, and only 31% of chest X-rays showed cardiomegaly and or bilateral infiltration. Electrocardiography (ECG) demonstrated normal sinus rhythm with around 59% ST elevation and rarely PR depression or T wave inversion, while the predominant echocardiographic feature was pericardial effusion. Management with colchicine was favored in most cases, followed by non-steroidal anti-inflammatory drugs (NSAIDs), and interventional therapy was only needed when patient developed cardiac tamponade. The majority of the reviewed studies reported either recovery or no continued clinical deterioration. The prevalence of COVID-19-related cardiac diseases is high, and pericarditis is a known extrapulmonary manifestation. However, pericardial effusion and cardiac tamponade are less prevalent and may require urgent intervention to prevent mortality. Pericarditis should be considered in patients with chest pain, ST elevation on ECG, a normal coronary angiogram, and COVID-19. We emphasize the importance of clinical examination, ECG, and echocardiogram for decision-making, and NSAIDs, colchicine, and corticosteroids are considered to be safe in the treatment of pericarditis/myopericarditis associated with COVID-19.
Collapse
|
5
|
mimouni H, Bouchlarhem A, Lafkih A, Haddar L, Lamzouri O, Bkiyar H, Housni B. Factors influencing the length of stay in the moroccan intensive care unit in patients surviving critical COVID-19 infection. Ann Med Surg (Lond) 2022; 79:104108. [PMID: 35784951 PMCID: PMC9238020 DOI: 10.1016/j.amsu.2022.104108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2022] [Revised: 06/26/2022] [Accepted: 06/26/2022] [Indexed: 11/29/2022] Open
Abstract
Introduction Methods Results Conclusion Our objective is to determine the factors that influence the length of hospitalization of patients admitted to an intensive care unit. The average length of hospitalization for a critical infection with COVID-19 is 6 days (SD = 7Days). The length of time between the consultation and the onset of symptoms higher than 8 days affects the length of hospitalization. During hospitalization, the use of mechanical ventilation, the use of tocilizumab, having a billateral nosocomial pneumonia are all factors that impact the length of hospitalization.
Collapse
Affiliation(s)
- Hamza mimouni
- Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco
- Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
- Corresponding author. Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
| | - Amine Bouchlarhem
- Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco
- Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Amine Lafkih
- Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco
- Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Leila Haddar
- Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco
- Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Oussama Lamzouri
- Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco
- Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
| | - Houssam Bkiyar
- Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco
- Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
- Mohammed First University, Faculty of Medecine and Pharmacy, LAMCESM, Oujda, Morocco
| | - Brahim Housni
- Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco
- Department of Anesthesiology and Intensive Care Unit, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco
- Mohammed First University, Faculty of Medecine and Pharmacy, LAMCESM, Oujda, Morocco
| |
Collapse
|
6
|
Győri Á, Decsi T, Stankovics J, Nyul Z, Környei M, Masszi G, Leibinger E, Mosdósi B. Case Report: Recurrent pericardial tamponade in a child with COVID-19. Front Pediatr 2022; 10:1026349. [PMID: 36353261 PMCID: PMC9637843 DOI: 10.3389/fped.2022.1026349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 09/28/2022] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND Pericarditis is rare in Coronavirus disease 2019 (Covid-19) infection and only a few cases were reported in children. CASE PRESENTATION We present the case of a 15-year-old boy with symptoms of high fever and worsening chest pain during COVID-19 infection. Chest computer tomography (CT) and echocardiography confirmed pericardial tamponade requiring urgent drainage. Despite antiviral drug treatment, after 18 days severe attack developed requiring repeated pericardiocentesis. High dose ibuprofen, colchicin and the interleukin-1 antagonist, anakinra were given. Clinical symptoms and laboratory parameters improved after seven days of treatment. Autoinflammatory diseases were also suspected in the background the severe pericarditis, but genetic analysis ruled out any mutations. CONCLUSION Pericarditis associated with COVID-19 infection may present in the acute phase or later as MIS-C. Though pericardial tamponade related to ongoing Covid-19 infection is rare in children, even biological treatment with interleukin-1 antagonist may be needed to control the inflammation.
Collapse
Affiliation(s)
- Ádám Győri
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| | - Tamás Decsi
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| | - József Stankovics
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| | - Zoltán Nyul
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| | - Mária Környei
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| | - György Masszi
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| | - Evelin Leibinger
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| | - Bernadett Mosdósi
- Department of Paediatrics, Clinical Centre, Faculty of Medicine, University of Pécs, Pécs, Hungary
| |
Collapse
|
7
|
Bouabdallaoui A, Taouihar S, Aabdi M, El Aidouni G, Bahouh C, Merbouh M, Bkiyar H, Ismaili N, Ouafi N, Housni B. Myocardial infarction complicated by cardiac arrest revealing SARS-COV-2 infection: Case report. Ann Med Surg (Lond) 2021; 67:102484. [PMID: 34127938 PMCID: PMC8188779 DOI: 10.1016/j.amsu.2021.102484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Revised: 05/31/2021] [Accepted: 06/05/2021] [Indexed: 12/15/2022] Open
Abstract
INTRODUCTION COVID19 infection is most often reveled by pulmonary symptoms, however cardiovascular manifestations has been observed revealing this infection with absence of respiratory symptoms. CLINICAL CASE A 62 year old female patient, with no medical history, admitted to the emergency room for epigastric pain, with no respiratory signs, the exploration revealed myocardial infarction with COVID 19 infection. CONCLUSION COVID19 infection manifest mainly with respiratory symptoms but it can also be revealed by cardiac manifestations with absence of respiratory symptoms.Physicians must be aware of these atypical manifestations and act accordingly to isolate patients to limit the spread of this disease.
Collapse
Affiliation(s)
- Amine Bouabdallaoui
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Salma Taouihar
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Mohamed Aabdi
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Ghizlane El Aidouni
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Choukri Bahouh
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Manal Merbouh
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Houssam Bkiyar
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Nabila Ismaili
- Cardiology Department, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Nouha Ouafi
- Cardiology Department, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Bahim Housni
- Intensive Care Unit, Mohammed VI University Hospital Center, Oujda, Morocco
- Mohammed Fist University, Faculty of Medicine and Pharmacy, Oujda, Morocco
- Oujda Medical Simulation Training Center, Morocco
| |
Collapse
|